PROJECT 2: MUSCLE CELL TRANSPLANTATION IN CANINE DMD Muscle-derived cell transplantation has the potential to effectively treat many human diseases, including muscular dystrophy. Studies in mdx mice demonstrate that normal muscle-derived cells engraft into skeletal muscle, effectively restore dystrophin expression and reconstitute the satellite cell pool. However, immune rejection of donor cells prevented long-term engraftment in human trials. We have induced immune tolerance in cxmd canines using a clinically relevant regimen of bone marrow transplantation, and show donor muscle-derived cell engraftment and survival for at least 24 weeks in the absence of immunosuppression. Our broad and long-term objective is to identify a cell population and accessory factors required for efficient engraftment of myogenic stem cells into diseased canine skeletal muscle that can be translated to human trials in muscular dystrophies. In addition to the immune tolerant cxmd model, we have developed a canine-to-mouse xenotransplantation model to rapidly and quantitatively compare canine muscle cell engraftment. We will use both of these models to test the broad hypothesis that transplantation of donor muscle-derived cells will successfully reconstitute normal muscle to clinically significant levels in a canine model of Duchenne muscular dystrophy. Demonstrating successful engraftment in a random-bred, large animal model will provide the basis for establishing a new clinical regimen of treating human skeletal muscle diseases.
The Specific Aims of our proposal will (Aim 1) determine whether using specific subpopulations of muscle-derived cells and modulating signaling pathways will enhance engraftment of transplanted donor cells and reconstitution of the satellite cell compartment, and (Aim2) determine whether the muscle stem cell transplantation techniques that are successful in mice can be directly translated to the immune tolerant canine cxmd model of Duchene muscular dystrophy.

Public Health Relevance

(Seeinstructions): Together, these studies will optimize cell isolation and delivery techniques using pre-clinical therapeutic cell transplant studies in mice and canines. The significance of this study is that canine models of hematopoietic cell transplantation and solid organ transplantation have been demonstrated to accurately predict clinical outcomes in humans. These studies will establish the best protocols for muscle cell transplantation and lead to future human clinical trials of muscle cell transplants for the treatment muscular dystrophies and for the delivery of systemic factors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS046788-10
Application #
8447007
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
10
Fiscal Year
2013
Total Cost
$250,988
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Whitehead, Nicholas P; Kim, Min Jeong; Bible, Kenneth L et al. (2015) A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Proc Natl Acad Sci U S A 112:12864-9
Muir, Lindsey A; Nguyen, Quynh G; Hauschka, Stephen D et al. (2014) Engraftment potential of dermal fibroblasts following in vivo myogenic conversion in immunocompetent dystrophic skeletal muscle. Mol Ther Methods Clin Dev 1:14025
Parker, Maura H; Tapscott, Stephen J (2013) Expanding donor muscle-derived cells for transplantation. Curr Protoc Stem Cell Biol Chapter 2:Unit 2C.4
Parker, Maura H; Loretz, Carol; Tyler, Ashlee E et al. (2012) Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment. Stem Cells 30:2212-20
Himeda, Charis L; Tai, Phillip W L; Hauschka, Stephen D (2012) Analysis of muscle gene transcription in cultured skeletal muscle cells. Methods Mol Biol 798:425-43
Gantz, Jay A; Palpant, Nathan J; Welikson, Robert E et al. (2012) Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells. PLoS One 7:e46971
Johnson, Eric K; Zhang, Liwen; Adams, Marvin E et al. (2012) Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS One 7:e43515
Tai, Phillip W L; Smith, Catherine L; Angello, John C et al. (2012) Analysis of fiber-type differences in reporter gene expression of β-gal transgenic muscle. Methods Mol Biol 798:445-59
Suga, Tomohiro; Kimura, En; Morioka, Yuka et al. (2011) Muscle fiber type-predominant promoter activity in lentiviral-mediated transgenic mouse. PLoS One 6:e16908
Gonçalves, Manuel A F V; Janssen, Josephine M; Nguyen, Quynh G et al. (2011) Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes. Mol Ther 19:1331-41

Showing the most recent 10 out of 32 publications